Clinical framework: Non-surgical treatment of infected implant

Link: how to determine if the treatment is non-surgical

Implaprotect Max is only product in the market offering effective treatment of mucositis due to the following characteristics:

  • Highly effective against a broad range of bacteria through antibiotic activity of piperacilline associated with tazobactam avoiding bacterial resistance and increasing local AB activity.

  • Hylauraonic acid with high mollecular weight enhances regeneration of hard and soft tissues

  • Easy to apply in infected site. After debridement medic will insert the active in 4 segments (north, east, south and west) mimicking parodontal probing.

  • When infected sites have been completely filled liquid preparation will appear at gingival border.

  • Pharmaco-cynethic activity for a period of 8 days

  • No or very limited side effects

  • Once opened medical device remains active for 8 weeks for other applications /reinforcements

Product composition

  • Powder bottle: Sodium Piperacilline 100 mg, Sodium Tazobactam 12,5 mg

  • Solution bottle: Sodium Hyaluronate 0,5%, water for injection on 5 ml

  • Three blunt needles and syringes

Product is patented and registered as Medical Device Class III

Treats 8-10 mild peri-implantitis or peri-implant mucositis cases